Neuroglee Therapeutics
Neuroglee secures $10m funding to advance home-based Alzheimer's treatment
Neuroglee secures $10m funding to advance home-based Alzheimer's treatment
Openspace Ventures led the Series A round.
Most Read
1. iX Biopharma secures $52.8m US contract for pain reliever trials 2. DBS’ $72m loan to PLife REIT to finance elder care in Japan 3. Aging population drives demand for durable medical equipment market 4. Hong Kong outlines ‘One plus Three’ model for life and health tech R&D 5. Tam Anh invests $77m in proton therapy systemResource Center
Read Here
Advertise
Sign Up
Events
Event News
He discusses how healthcare systems in Asia Pacific need to evolve beyond simply expanding coverage and towards delivering equitable, sustainable, and high-impact care.
